Literature DB >> 18853982

Clinical review of the management of fulminant clostridium difficile infection.

M Raffat Jaber1, Snorri Olafsson, Wesley L Fung, Mark E Reeves.   

Abstract

BACKGROUND: Clostridium difficile infection (CDI) is a frequent cause of morbidity and mortality among elderly hospitalized patients. A small but increasing number of patients have developed fulminant CDI, and a significant number of these patients require emergency colectomy. In this review, we discuss the risk factors, pathophysiology, diagnosis, and management of fulminant CDI. DATA SOURCES: A literature search (Medline, Embase, Cochrane Library, Biosis, Science Citation Index, Ovid Journals) was performed from the period between January 1980 and June 2008 using the key words "Clostridium difficile,""pseudomembranous enterocolitis,""colectomy,""acute abdomen,""antibiotic-associated diarrhea," or "fulminant Clostridium difficile colitis." Articles not in English or not related to human subjects were excluded. For this review, we analyzed the articles identified in our original search and those articles cited in the original review articles. No randomized trials were found on the surgical management of fulminant CDI and only retrospective studies with a minimum of five patients were used in the review. With respect to medical treatment, we based our review on guideline articles, systematic reviews, and available randomized trials.
CONCLUSION: Both the incidence and severity of CDI are increasing. Fulminant CDI is underappreciated as a life-threatening disease because of a lack of awareness of its severity and its nonspecific clinical syndrome. Early diagnosis and treatment are essential for a good outcome, and early surgical intervention should be used in patients who are unresponsive to medical therapy. The surgical procedure of choice is a total abdominal colectomy with end ileostomy, although the mortality rate remains high.

Entities:  

Mesh:

Year:  2008        PMID: 18853982     DOI: 10.1111/j.1572-0241.2008.02198.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  21 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.

Authors:  Emily N Tixier; Elijah Verheyen; Ryan C Ungaro; Ari M Grinspan
Journal:  Aliment Pharmacol Ther       Date:  2019-10-14       Impact factor: 8.171

3.  The economic burden of Clostridium difficile.

Authors:  S M McGlone; R R Bailey; S M Zimmer; M J Popovich; Y Tian; P Ufberg; R R Muder; B Y Lee
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

Review 4.  Pseudomembranous colitis.

Authors:  Priya D Farooq; Nathalie H Urrunaga; Derek M Tang; Erik C von Rosenvinge
Journal:  Dis Mon       Date:  2015-03-11       Impact factor: 3.800

5.  Evolving concepts in Clostridium difficile colitis.

Authors:  Naomi G Diggs; Christina M Surawicz
Journal:  Curr Gastroenterol Rep       Date:  2009-10

Review 6.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Intracolonic vancomycin for severe Clostridium difficile colitis.

Authors:  Peter K Kim; Heesun C Huh; Hillel W Cohen; Elyssa J Feinberg; Salman Ahmad; Christina Coyle; Sheldon Teperman; Hugh Boothe
Journal:  Surg Infect (Larchmt)       Date:  2013-04-05       Impact factor: 2.150

9.  Anti-Clostridium difficile potential of tetramic acid derivatives from Pseudomonas aeruginosa quorum-sensing autoinducers.

Authors:  Chihiro Ueda; Kazuhiro Tateda; Manabu Horikawa; Soichiro Kimura; Yoshikazu Ishii; Kaoru Nomura; Kanako Yamada; Takashi Suematsu; Yasuhisa Inoue; Masaji Ishiguro; Shinichi Miyairi; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

Review 10.  [Nosocomial infections: MRSA und CDAD as a challenge].

Authors:  W V Kern; M Dettenkofer
Journal:  Internist (Berl)       Date:  2009-06       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.